• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

分析在现代腹主动脉瘤治疗时代,使用高危标准选择手术与血管内修复的结果。

Analysis of outcome after using high-risk criteria selection to surgery versus endovascular repair in the modern era of abdominal aortic aneurysm treatment.

机构信息

Service de chirurgie cardio vasculaire, CHU Le Bocage, Dijon, France.

出版信息

Eur J Vasc Endovasc Surg. 2010 Apr;39(4):403-9. doi: 10.1016/j.ejvs.2009.12.009. Epub 2010 Jan 8.

DOI:10.1016/j.ejvs.2009.12.009
PMID:20060753
Abstract

INTRODUCTION

The concept of high-risk patients suggests that such patients will experience a higher rate of postoperative complications and worse short- and long-term outcomes, and should therefore benefit from the use of endovascular techniques for aortic abdominal aneurysm (AAA) repair. The primary goal of this study was to assess the relevance of the different high-risk criteria, defined by the French health agency Agence Française de Sécurité Sanitaire des Produits de Santé (AFSSAPS) in a single-centre continuous series. Secondary goals were to retrospectively compare the incidence of postoperative complications and short- and long-term survival in three groups of patients.

MATERIALS AND METHODS

Between January 1999 and December 2006, details of all the patients undergoing elective surgery for AAA in our hospital were recorded into a prospective registry (n=626). Three groups were considered according to the level of risk and type of repair defined by the AFSSAPS: endovascular aortic aneurysm repair (EVAR) high-risk (HR) (at least one high-risk factor and EVAR, n=138), open HR (at least one high-risk factor and open repair, n=134) and open low-risk (LR) (no high-risk factors and open repair, n=344). None of the low-risk patients were treated using an endovascular approach. The demographics, preoperative risk factors, intra-, postoperative data and short- and long-term survival were compared between the groups. Interrelations among the set of high-risk criteria for mortality were calculated using multiple correspondence analysis (MCA).

RESULTS

The distribution of high-risk criteria was similar in both high-risk groups, except for age, heart failure and hostile abdomen, which were significantly more frequent in EVAR HR. Operation time, blood loss and length of stay in an intensive care unit and hospital were significantly lower in the EVAR HR group. The 30-day mortality and survival rates at 5 years were 5.4 and 59.4% for EVAR HR, 3.7 and 70.4% for open HR and 2.3 and 83.7% for open LR, respectively, with no significant difference between the three groups for the mortality, but a significant higher survival at 5 years for the open LR versus both high-risk groups.

CONCLUSION

The high-risk AFSSAPS criteria were not predictive of postoperative mortality and should not be used to determine the choice of treatment technique. Other criteria therefore need to be established to determine whether open or EVAR repair should be used.

摘要

简介

高危患者的概念表明,此类患者术后并发症发生率和短期及长期预后更差,因此应受益于血管内技术治疗腹主动脉瘤(AAA)。本研究的主要目的是评估法国卫生机构法国保健产品安全局(AFSSAPS)在单一中心连续系列中定义的不同高危标准的相关性。次要目标是回顾性比较三组患者术后并发症和短期及长期生存率的发生率。

材料与方法

1999 年 1 月至 2006 年 12 月,我院所有择期手术治疗 AAA 的患者的详细信息均记录在一个前瞻性登记处(n=626)中。根据 AFSSAPS 定义的风险水平和修复类型,将患者分为三组:血管内主动脉瘤修复(EVAR)高危(HR)(至少存在一个高危因素和 EVAR,n=138)、开放 HR(至少存在一个高危因素和开放修复,n=134)和开放低危(LR)(无高危因素和开放修复,n=344)。没有任何低危患者采用血管内方法治疗。比较了三组患者的人口统计学、术前危险因素、术中、术后数据以及短期和长期生存率。使用多元对应分析(MCA)计算死亡率相关高危标准的相互关系。

结果

两组高危患者的高危标准分布相似,除了年龄、心力衰竭和敌对腹部,EVAR HR 中更为常见。EVAR HR 组的手术时间、出血量和 ICU 及医院住院时间明显较低。EVAR HR 组的 30 天死亡率和 5 年生存率分别为 5.4%和 59.4%,开放 HR 组分别为 3.7%和 70.4%,开放 LR 组分别为 2.3%和 83.7%,三组间死亡率无显著性差异,但开放 LR 组的 5 年生存率明显高于两组高危组。

结论

AFSSAPS 的高危标准不能预测术后死亡率,不应用于确定治疗技术的选择。因此,需要建立其他标准来确定是采用开放或 EVAR 修复。

相似文献

1
Analysis of outcome after using high-risk criteria selection to surgery versus endovascular repair in the modern era of abdominal aortic aneurysm treatment.分析在现代腹主动脉瘤治疗时代,使用高危标准选择手术与血管内修复的结果。
Eur J Vasc Endovasc Surg. 2010 Apr;39(4):403-9. doi: 10.1016/j.ejvs.2009.12.009. Epub 2010 Jan 8.
2
Improving results of elective abdominal aortic aneurysm repair at a low-volume hospital by risk-adjusted selection of treatment in the endovascular era.在血管内治疗时代,通过风险调整后的治疗选择来提高低容量医院择期腹主动脉瘤修复的效果。
Cardiovasc Intervent Radiol. 2009 Sep;32(5):918-22. doi: 10.1007/s00270-009-9538-2. Epub 2009 Mar 19.
3
Endovascular abdominal aortic aneurysm repair in high risk patients: outcomes of management.高危患者的腹主动脉瘤腔内修复术:治疗结果
J Med Assoc Thai. 2007 Oct;90(10):2080-9.
4
Acceptable risk but small benefit of endovascular aneurysm repair in nonagenarians.血管内动脉瘤修复术对九旬老人而言,风险可接受但获益微小。
Ann Vasc Surg. 2010 May;24(4):441-6. doi: 10.1016/j.avsg.2009.10.009. Epub 2009 Dec 29.
5
Measure what matters: institutional outcome data are superior to the use of surrogate markers to define "center of excellence" for abdominal aortic aneurysm repair.衡量关键指标:机构结局数据优于使用替代指标来定义腹主动脉瘤修复的“卓越中心”。
Ann Vasc Surg. 2008 May-Jun;22(3):328-34. doi: 10.1016/j.avsg.2007.09.013. Epub 2008 Apr 14.
6
Impact of the introduction of endovascular aneurysm repair in high-risk patients on our practice of elective treatment of infrarenal abdominal aortic aneurysms.高危患者血管内动脉瘤修复术的引入对我们治疗肾下腹主动脉瘤的择期治疗实践的影响。
Ann Vasc Surg. 2008 Nov;22(6):829-33. doi: 10.1016/j.avsg.2008.03.007. Epub 2008 Sep 19.
7
Abdominal aortic aneurysm repair in obese patients: improved outcome after endovascular treatment compared with open surgery.肥胖患者腹主动脉瘤修复术:与开放手术相比,血管内治疗后预后改善。
Vasc Endovascular Surg. 2010 Feb;44(2):105-9. doi: 10.1177/1538574409351989. Epub 2009 Dec 23.
8
Outcome and survival of patients aged 75 years and older compared to younger patients after ruptured abdominal aortic aneurysm repair: do the results justify the effort?与年轻患者相比,75岁及以上患者腹主动脉瘤破裂修复后的结局和生存率:这些结果是否证明付出的努力是值得的?
Ann Vasc Surg. 2009 Jul-Aug;23(4):469-77. doi: 10.1016/j.avsg.2008.10.009. Epub 2009 Jan 10.
9
The importance of anatomical suitability and fitness for the outcome of endovascular repair of ruptured abdominal aortic aneurysm.解剖学适宜性和适合性对破裂腹主动脉瘤血管内修复结果的重要性。
Eur J Vasc Endovasc Surg. 2009 Sep;38(3):285-90. doi: 10.1016/j.ejvs.2009.05.018. Epub 2009 Jul 2.
10
Outcome of abdominal aortic aneurysm repair in the era of endovascular treatment.血管内治疗时代腹主动脉瘤修复的结果
Br J Surg. 2004 May;91(5):563-8. doi: 10.1002/bjs.4529.

引用本文的文献

1
Renal Artery Stent-Graft Implantation Using the Retrograde Approach in a Patient Who Developed a Renal Artery Aneurysm after Thoracoabdominal Aortic Repair.经逆行途径行肾动脉支架植入术治疗胸腹主动脉修复术后发生肾动脉动脉瘤的患者
Surg Case Rep. 2025;11(1). doi: 10.70352/scrj.cr.24-0121. Epub 2025 Apr 18.
2
Early and late results of open surgical and endovascular treatment of infrarenal abdominal aortic aneurysms, selected according to surgical risk.根据手术风险选择的肾下腹主动脉瘤开放手术和血管内治疗的早期和晚期结果
J Vasc Bras. 2021 Nov 29;20:e20200024. doi: 10.1590/1677-5449.200024. eCollection 2021.
3
Is Chimney EVAR an Acceptable Endovascular Technique ?
烟囱式腔内隔绝术是一种可接受的血管腔内技术吗?
EJVES Short Rep. 2019 Jan 30;42:43. doi: 10.1016/j.ejvssr.2019.01.001. eCollection 2019.
4
Systematic Review and Meta-analysis of Long-term survival After Elective Infrarenal Abdominal Aortic Aneurysm Repair 1969-2011: 5 Year Survival Remains Poor Despite Advances in Medical Care and Treatment Strategies.1969 - 2011年选择性肾下腹主动脉瘤修复术后长期生存的系统评价和荟萃分析:尽管医疗护理和治疗策略有所进步,但5年生存率仍然很低。
Eur J Vasc Endovasc Surg. 2015 Sep;50(3):320-30. doi: 10.1016/j.ejvs.2015.05.004. Epub 2015 Jun 23.
5
Open versus Endovascular Repair of Abdominal Aortic Aneurysm in the Elective and Emergent Setting in a Pooled Population of 37,781 Patients: A Systematic Review and Meta-Analysis.37781例患者合并人群中择期和急诊情况下腹主动脉瘤开放修复与血管腔内修复的系统评价和Meta分析
ISRN Cardiol. 2014 Apr 2;2014:149243. doi: 10.1155/2014/149243. eCollection 2014.
6
Clinical and economic outcomes after surgical aortic valve replacement in Medicare patients.医疗保险患者行主动脉瓣置换术后的临床和经济结局。
Risk Manag Healthc Policy. 2012;5:117-26. doi: 10.2147/RMHP.S34587. Epub 2012 Oct 31.